Dr Fauci’s diabolical deal

Dr Fauci’s diabolical deal, by Rebecca Weiser.

You’d think Fauci’s choice would be easy. Way back in early to mid January, when China still wasn’t admitting Sars-Cov-2 was contagious, it tested every drug that showed promise treating the original Sars in test tubes to see what might work with the new virus.

There were two front runners. A cheap generic with a well-known safety profile — chloroquine (CQ) and its even safer analogue [hydroxychloroquine] HCQ — and remdesivir (RDV), an unknown, experimental drug under patent to Gilead Sciences. …

Fauci ignored the cheap generic and ploughed $70 million of taxpayer money into trials for RDV, the WHO committed to trialling it too, and for good measure the Wuhan Institute of Virology quietly lodged a patent application covering China for RDV on January 21, before it released the results of its secret trials. None of them were interested in HCQ and, despite the WHO belatedly agreeing to add HCQ on to its large multi-country clinical trials, they still are not.

The results of CQ and HCQ in Chinese trials in February were so impressive that an expert committee — headed by Zhong Nanshan, the scientist who pioneered the effective treatment of Sars —declared that it be incorporated as standard treatment. Since then, at least five other trials into the two drugs and an avalanche of evidence from countries in the Mediterranean, Africa, Latin America and Asia have shown they reduce mortality, reduce viral load , reduce hospitalisation, reduce progression to severe illness, and speed up recovery, particularly when treatment is started early. …

And RDV? The first peer-reviewed, randomised, double-blind, placebo-controlled trial of RDV was published in the Lancet on 29 April and it was clear cut. RDV was not just a dud, 66 per cent of patients had adverse events including multiple organ dysfunction, septic shock, acute kidney injury, low blood pressure, liver damage and acute respiratory failure. Did that deter Fauci? Not at all. He decided to release the results of his trial early and claimed they showed patients got better four days faster and there was a slight, statistically insignificant, improvement in mortality. We’ll have to take his word for it because he didn’t release any data, much less subject it to peer review. …

Yet, on the basis of the invisible study, Fauci said RDV would become ‘standard of care,’ and the FDA issued an Emergency Use Authorisation (EUA) for its use with seriously ill hospitalised patients. …

The dreadful politicization of everything by the crazy left:

Many in the mainstream media have made no secret of the fact that they want HCQ to fail because it was touted by Trump. Others seem to want the virus to do as much damage as possible in the hope that it destroys his chances of re-election. As one journalist put it, ‘Remdesivir may not be the effective coronavirus treatment the world desperately needs, but it has… one strong point in (its) favour: the Make America Great Again crowd hates it.’

Something stinks. Read it all.